Bayer
HealthCare Pharmaceuticals appoints Dieter Weinand as president effective from August 1, 2014. Presently, Dieter Weinand is the president - global commercialisation & portfolio management at Otsuka Pharmaceutical Development & Commercialisation Inc., Princeton, New Jersey.
"We welcome Weinand to our management team. Based on his extensive commercial experience in the pharmaceutical industry, Dieter Weinand will drive the growth of our pharmaceutical business further and maximise the value of our product portfolio," said Olivier Brandicourt, chief executive officer, of Bayer HealthCare.
Dieter Weinand has more than 25 years of experience in various commercial operative and strategic executive roles in the pharmaceutical industry. He has been responsible for different markets such as Asia-Pacific, Europe, Middle East, Africa, Latin America and the USA at companies including Pfizer and Bristol-Myers Squibb as well as for the marketing of products in different therapeutic areas such as cardiology, oncology, pulmonology, dermatology, immunology and inflammation.
Weinand earned a MS in Pharmacology/Toxicology from Long Island University, New York, as well as a B.A. in Biology from Concordia College in New York.